Integrated BioTherapeutics

IBT is a biotechnology company dedicated to discovering novel vaccines and therapies for emerging infectious diseases. IBT's bacterial program primarily focuses on countermeasures against staphylococcal infections, targeting various toxins produced by Staphylococcus aureus. IBT's antiviral pipeline includes unique pan-filovirus antibody candidates, vaccines, and multiple other product candidates targeting emerging viruses.